Valuation Tonix Pharmaceuticals Nasdaq

Stocks

End-of-day quote Nasdaq 05/02/2024			5-day change	1st Jan Change
0.3222 ^USD	-2.36%		+2.32%	-20.05%

08/09	Tonix Pharmaceuticals Holding Corp. Announces Appointment of Thomas Englese to Chief Commercial Officer, Effective September 8, 2026	CI
19/08	Tonix Pharmaceuticals Holding Corp. Announces Appointment of Seth Lederman as Interim Chief Medical Officer	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	177.4	22.42	23.62	61.64	193.6	225.7	-	-
Change	-	-87.36%	5.35%	160.94%	214.02%	16.61%	-	-
Enterprise Value (EV)	177.4	22.42	23.62	61.64	193.6	225.7	225.7	225.7
Change	-	-87.36%	5.35%	160.94%	214.02%	16.61%	0%	0%
P/E	-1.38x	-0.12x	-0.06x	-0.19x	-1.07x	-1.34x	-1.99x	-3.87x
PBR	-	-	-	-	-	-	-	-
PEG	-	0x	0x	0x	0x	0x	0.1x	0.1x
Capitalization / Revenue	-	-	3.04x	6.11x	14.8x	4.1x	2.04x	1.24x
EV / Revenue	-	-	0x	0x	0x	4.1x	2.04x	1.24x
EV / EBITDA	-	-	-	-	-	-	-	-
EV / EBIT	-0x	-0x	-0x	-0x	-0x	-1.3x	-1.39x	-1.87x
EV / FCF	-	-	-	-	-	-1.16x	-1.1x	-1.41x
FCF Yield	-	-	-	-	-	-86.4%	-90.8%	-70.9%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-1,66,400	-65,400	-21,920	-176.6	-14.57	-9.792	-6.617	-3.397
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	-	-	7.768	10.09	13.11	55	110.9	181.4
EBITDA	-	-	-	-	-	-	-	-
EBIT ¹	-92.31	-112.1	-118.4	-136.7	-125.7	-173.3	-161.9	-120.7
Net income ¹	-92.29	-116.9	-116.7	-130	-124	-168.7	-164.3	-115.4
Net Debt	-	-	-	-	-	-	-	-
Reference price ²	2,28,928.00	7,796.00	1,289.60	32.98	15.62	13.16	13.16	13.16
Nbr of stocks (in thousands)	0.78	2.88	18.3	1,869	12,392	17,151	-	-
Announcement Date	14/03/22	13/03/23	01/04/24	18/03/25	12/03/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	31.99x	11.64x	23.74x	0.62%	1,00200Cr
JOHNSON & JOHNSON	29.94x	-	-	2%	65TCr
ABBVIE INC.	31.86x	7.4x	15.38x	2.76%	44TCr
ROCHE HOLDING AG	19.06x	4.64x	11.51x	2.86%	35TCr
NOVARTIS AG	19.62x	5.13x	12.72x	3.16%	26TCr
ASTRAZENECA PLC	20.69x	4.25x	12.14x	2.08%	25TCr
AMGEN INC.	24.87x	6.52x	11.97x	2.57%	21TCr
NOVO NORDISK A/S	13.02x	4.72x	9.85x	3.87%	20TCr
GILEAD SCIENCES, INC.	-44.81x	6.47x	25.27x	2.25%	18TCr
Average	16.25x	6.35x	15.32x	2.46%	39.37TCr
Weighted average by Cap.	23.18x	7.75x	17.28x	2.03%